Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04020185
Title Safety and Efficacy Study of IMSA101 in Refractory Malignancies
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors ImmuneSensor Therapeutics Inc.
Indications

melanoma

lung non-small cell carcinoma

gastroesophageal cancer

hematologic cancer

renal cell carcinoma

progesterone-receptor negative breast cancer

hepatocellular carcinoma

estrogen-receptor negative breast cancer

head and neck cancer

Advanced Solid Tumor

Therapies

IMSA101 + unspecified PD-L1 antibody

IMSA101 + unspecified PD-1 antibody

IMSA101

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Honor Health Recruiting Scottsdale Arizona 85260 United States Details
UC San Diego Moores Cancer Center Recruiting La Jolla California 92093 United States Details
Northwestern University Recruiting Chicago Illinois 60611 United States Details
Atlantic Health System/Morristown Medical Center Recruiting Morristown New Jersey 07962 United States Details
UT Southwestern Recruiting Dallas Texas 75390 United States Details
MD Anderson Cancer Center Recruiting Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field